What is VIVS's earnings growth forecast for 2026-2026?
(NASDAQ: VIVS) Vivosim Labs's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.91%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.12%.
Vivosim Labs's earnings in 2025 is -$2,488,000.
In 2026, VIVS is forecast to generate -$23,407,532 in earnings, with the lowest earnings forecast at -$23,407,532 and the highest earnings forecast at -$23,407,532.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.